RBM16 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.8588464101299E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.33440000452623E-08 |
Normal-vs-Stage2 |
6.8580000001095E-07 |
Normal-vs-Stage3 |
1.89515070303514E-12 |
Normal-vs-Stage4 |
1.74538161701321E-12 |
Stage1-vs-Stage2 |
1.548160E-01 |
Stage1-vs-Stage3 |
5.381000E-03 |
Stage1-vs-Stage4 |
3.841300E-04 |
Stage2-vs-Stage3 |
6.279200E-01 |
Stage2-vs-Stage4 |
2.139000E-01 |
Stage3-vs-Stage4 |
2.711200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.9755755071601E-12 |
Normal-vs-AfricanAmerican |
3.01910000000127E-07 |
Normal-vs-Asian |
9.400100E-02 |
Caucasian-vs-AfricanAmerican |
8.312600E-01 |
Caucasian-vs-Asian |
4.207000E-01 |
AfricanAmerican-vs-Asian |
4.086800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.52353693497298E-13 |
Normal-vs-Female |
4.12159999463313E-08 |
Male-vs-Female |
8.342300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.21699999999725E-05 |
Normal-vs-Age(41-60Yrs) |
1.09340000387093E-08 |
Normal-vs-Age(61-80Yrs) |
2.08522088485097E-12 |
Normal-vs-Age(81-100Yrs) |
7.64409999964855E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.594400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.768200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.332200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.848300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.096200E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.714800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.384000E-01 |
Normal-vs-Grade 2 |
2.18760000003648E-06 |
Normal-vs-Grade 3 |
1.62592161956354E-12 |
Normal-vs-Grade 4 |
1.626032641866E-12 |
Grade 1-vs-Grade 2 |
1.231580E-01 |
Grade 1-vs-Grade 3 |
7.980800E-04 |
Grade 1-vs-Grade 4 |
2.19599999999875E-05 |
Grade 2-vs-Grade 3 |
1.361990E-04 |
Grade 2-vs-Grade 4 |
1.00890000021003E-07 |
Grade 3-vs-Grade 4 |
9.299500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.23029999999658E-05 |
Normal-vs-ccB subtype |
1.71573866225572E-12 |
ccA subtype-vs-ccB subtype |
7.54889999954322E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.65220004344491E-09 |
Normal-vs-N1 |
2.57199999997848E-06 |
N0-vs-N1 |
6.576300E-02 |
|
|